Dow Up 0.51% Nasdaq Up 0.24%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
2.09 Down 0.02(0.95%) Nov 21, 4:02PM EST
Prev Close:2.11
Open:2.10
Bid:1.84 x 100
Ask:2.70 x 3100
1y Target Est:3.83
Beta:0.24
Next Earnings Date:N/A
Day's Range:2.05 - 2.13
52wk Range:1.86 - 5.30
Volume:216,416
Avg Vol (3m):453,597
Market Cap:194.31M
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXDown 0.95%194.31M
SHPGDown 0.54%41.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback